newsfilter
← Latest News
ACCESS Newswire·

Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

SEATTLE, WA / ACCESS Newswire / April 3, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel immune-oncology